AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Japan · Delayed Price · Currency is JPY

825.00

-22.00 (-2.60%)

Nov 6, 2026, 3:30 PM JST

Market Cap	12.01B +1.2%
Revenue (ttm)	34.32B +5.1%
Net Income	1.20B -17.3%
EPS	82.83 -19.5%
Shares Out	14.56M
PE Ratio	9.96
Forward PE	n/a
Dividend	44.00 (5.33%)
Ex-Dividend Date	Aug 28, 2026

Volume	69,400
Open	841.00
Previous Close	847.00
Day's Range	825.00 - 841.00
52-Week Range	810.00 - 918.00
Beta	0.49
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 15, 2026

About AFC-HD AMS Life Science

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs,... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1969

Employees 1,008

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 2927

Full Company Profile

Financial Performance

In fiscal year 2026, AFC-HD AMS Life Science's revenue was 34.32 billion, an increase of 5.11% compared to the previous year's 32.66 billion. Earnings were 1.20 billion, a decrease of -17.27%.

Financial Statements